SYRS Syros Pharmaceuticals Inc

Syros Pharmaceuticals Inc is a biopharmaceutical company pioneering an understanding of the region of the genome controlling the activation and repression of genes.

As of 07/01/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/30/2016
Outstanding shares:  62,819,046
Average volume:  954,214
Market cap:   $60,256,029
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BYMX5N2
Valuation   (See tab for details)
PE ratio:   -0.62
PB ratio:   0.96
PS ratio:   2.50
Return on equity:   -155.36%
Net income %:   -404.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy